Open nephron-sparing surgery in renal tumors with normal contralateral kidney: A single centre experience of 8 years.
BACKGROUND
We present our eight-year experience with open nephron-sparing surgery (NSS) in renal tumors with contralateral normal kidney to assess its oncological efficacy and safety.


METHODS
Thirty-six patients undergoing open NSS for small localized renal tumors with normal contralateral kidney from January 1998 to August 2006 were studied regarding demographic, clinical and pathological characteristics along with long-term follow-up.


RESULTS
The mean age was 48.28 +/- 9.5 years. The mean tumor size was 3.72 cm (range 1.5-6). The following surgeries were performed: Wedge resection-13, partial polar nephrectomy-15, segmental resection-eight. The following techniques were used for vascular control: clamping and cooling-eight, warm ischemia-12, a novel technique of serial encirclage-16. The mean warm ischemia time was 23.2 +/- 3.2 min. The mean operating time was 190.07 +/- 11.3 min. The mean estimated blood loss was 331 +/- 17.4 ml. The majority of renal tumors were renal cell carcinoma (97.22%). There were no positive surgical margins. There were no major intraoperative and postoperative complications. The mean follow up was 52.1 months (range 4-80) with no case showing progression to renal insufficiency (defined as serum creatinine > 2 mg/dl). There was only one local recurrence. However, four distant metastases were reported. The five-year cancer-specific survival, recurrence-free survival and overall survival were 94.4%, 88.88% and 86.11% respectively.


CONCLUSIONS
In patients with solitary, small localized, unilateral renal tumors with normal contralateral kidney, elective open NSS is feasible, safe and provides excellent long-term local control and oncological efficacy with functional benefits.
Gupta
N P
NP
Department of Urology, All India Institute of Medical Sciences, New Delhi, India.
Kumar
A
A
Hemal
A K
AK
Dogra
P N
PN
Seth
A
A
Kumar
R
R
J Urol. 2004 Jan;171(1):130-4
14665860
J Urol. 2003 Jul;170(1):64-8
12796646
Urology. 2002 Jun;59(6):816-20
12031359
BJU Int. 2006 Jun;97(6):1211-5
16686713
J Urol. 2006 Jun;175(6):2027-31
16697793
J Urol. 2001 Jul;166(1):6-18
11435813
J Urol. 2004 Mar;171(3):1066-70
14767272
BJU Int. 2005 Mar;95 Suppl 2:35-40
15720333
J Urol. 2004 Jun;171(6 Pt 1):2181-5, quiz 2435
15126781
Mayo Clin Proc. 2000 Dec;75(12):1236-42
11126830
BJU Int. 2003 Oct;92(6):567-71
14511035
J Urol. 2002 Feb;167(2 Pt 2):884-9; discussion 889-90
11905916
J Urol. 2000 Mar;163(3):730-6
10687966
J Urol. 1999 Jan;161(1):33-4; discussion 34-5
10037361
Urology. 2004 May;63(5):976-8
15134994
J Urol. 2005 Sep;174(3):855-8
16093969
J Urol. 1999 Dec;162(6):1930-3
10569540
Br J Urol. 1998 Sep;82(3):321-4
9772865